Correlation Between LAir Liquide and Novozymes

Can any of the company-specific risk be diversified away by investing in both LAir Liquide and Novozymes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LAir Liquide and Novozymes into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between LAir Liquide SA and Novozymes AS B, you can compare the effects of market volatilities on LAir Liquide and Novozymes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LAir Liquide with a short position of Novozymes. Check out your portfolio center. Please also check ongoing floating volatility patterns of LAir Liquide and Novozymes.

Diversification Opportunities for LAir Liquide and Novozymes

0.86

Correlation Coefficient

LAir Liquide  Novozymes

Very poor diversification

The 3 months correlation between LAir and Novozymes is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding LAir Liquide SA and Novozymes AS B in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novozymes AS B and LAir Liquide is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LAir Liquide SA are associated (or correlated) with Novozymes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novozymes AS B has no effect on the direction of LAir Liquide i.e., LAir Liquide and Novozymes go up and down completely randomly.

Pair Corralation between LAir Liquide and Novozymes

Assuming the 90 days horizon LAir Liquide SA is expected to under-perform the Novozymes. But the pink sheet apears to be less risky and, when comparing its historical volatility, LAir Liquide SA is 1.84 times less risky than Novozymes. The pink sheet trades about -0.39 of its potential returns per unit of risk. The Novozymes AS B is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest  6,145  in Novozymes AS B on September 4, 2024 and sell it today you would lose (431.00) from holding Novozymes AS B or give up 7.01% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	95.24%
Values	Daily Returns

LAir Liquide SA  vs.  Novozymes AS B

LAir Liquide SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days LAir Liquide SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Novozymes AS B

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novozymes AS B has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's primary indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with LAir Liquide and Novozymes

The main advantage of trading using opposite LAir Liquide and Novozymes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LAir Liquide position performs unexpectedly, Novozymes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novozymes will offset losses from the drop in Novozymes' long position.

The idea behind LAir Liquide SA and Novozymes AS B pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.